Table 2.
Item | Input | Low | High | Reference |
---|---|---|---|---|
Cost of family history screen | 1st/3rd of level III office visit, new patient ($40) | 32 | 100 | HCPC 99204 (36) |
No. eligible screenees, U.S. | Adults age 40–44: 22,441,863 | — | — | U.S. Census (37) |
Proportion with positive FmHx | 9% | 8% | 15% | PLCO trial (38) |
Lead time for polyps | 6.4 y | 4 y | 9 y | Moss et al. (39), Launoy et al. (40) |
Proportion of polyps that do not progress | 0.95 | 0.8 | 0.99 | Shinya et al. (15), Rex et al. (16), Gschwantler et al. (17) |
Risk of perforation, screening colonoscopy | 1.96 per 1,000 | 0.5 per 1,000 | 2.5 per 1,000 | Gatto et al. (41) |
Screening colonoscopy cost | $723 | $600 | $1,500 | HCPC G0105* (36, 42) |
Proportion of positives receiving colonoscopy (adherence) | 75% | 50% | 100% | Estimate |
Relative risk of developing colorectal cancer in person With family history, age 40–50 | 2.25 | 1.8 | 2.7 | Johns et al. (43) |
Probability of developing colorectal cancer, age 40–50 | 0.185% | 0.148% | 0.222% | SEER STAT (44) |
Life expectancy benefit for avoidance of colorectal cancer age 40–50 | 10.35 | 5 | 12 | Calculated (see article), Sonnenberg et al. (45) |
Cost of treating perforation | $15,684 | $10,000 | $20,000 | |
Cost of polypectomy and pathologic evaluation | $1,036 | $800 | $1,500 | HCPC 45385, 88305 † (36, 42) |
Lifetime cost of treatment for colorectal cancer in age 40–50 | $51,600 | $40,000 | $60,000 | Brown et al. (46) |
Efficacy of colonoscopy for removing precancerous polyps | 100% | Estimate | ||
Discount rate for future costs and life years | 3% per annum | Gold et al. (47) |
Abbreviations: HCPC, Healthcare Common Procedure Code; PLCO, prostate, lung, colon, and ovary.
HCPC G0105 screening colonoscopy, high-risk individual (physician fee, $390; facility fee, $333).
HCPC 45385 lesion removal colonoscopy (physician fee, $599; facility fee, $333); 88305 Tissue exam by pathologist ($104).